Nabhan Chadi, Feinberg Bruce A
Cardinal Health, Dublin, OH.
J Oncol Pract. 2017 Aug;13(8):499-506. doi: 10.1200/JOP.2017.022947. Epub 2017 Jun 15.
The ASCO Value Framework, National Comprehensive Cancer Network Evidence Blocks, Memorial Sloan Kettering's DrugAbacus, and Institute for Clinical and Economic Review incremental cost-effectiveness ratio calculator are value-based methodologies that attempt to address the disproportionate increase in cancer care spending. These calculators can be used as an initial step for discussing cost versus value, but they fall short in recognizing the importance of the cancer journey because they do not fully factor the patient's perspective or the global cost of care. This timely review highlights both the limitations and the advantages of each value calculator and suggests opportunities for refinement. Practicing oncologists, payers, and manufacturers should be familiar with value-based calculators because the role these tools play in cost containment is likely to be hotly debated.
美国临床肿瘤学会价值框架、美国国立综合癌症网络证据模块、纪念斯隆凯特琳癌症中心的药物算盘以及临床与经济评论学会增量成本效益比计算器都是基于价值的方法，旨在应对癌症治疗费用不成比例的增长。这些计算器可作为讨论成本与价值的第一步，但它们在认识癌症治疗过程的重要性方面存在不足，因为它们没有充分考虑患者的观点或整体护理成本。这篇及时的综述突出了每个价值计算器的局限性和优势，并提出了改进的机会。执业肿瘤学家、支付方和制药商应熟悉基于价值的计算器，因为这些工具在成本控制中所起的作用可能会引发激烈的争论。
